TAE226, a dual inhibitor of focal adhesion kinase and insulin-like growth factor-I receptor, is effective for Ewing sarcoma.
Saved in:
| Title: | TAE226, a dual inhibitor of focal adhesion kinase and insulin-like growth factor-I receptor, is effective for Ewing sarcoma. |
|---|---|
| Authors: | Moritake H; Division of Pediatrics, Faculty of Medicine, University of Miyazaki, Miyazaki, Japan., Saito Y; Division of Pediatrics, Faculty of Medicine, University of Miyazaki, Miyazaki, Japan., Sawa D; Division of Pediatrics, Faculty of Medicine, University of Miyazaki, Miyazaki, Japan., Sameshima N; Department of Pathology, Faculty of Medicine, University of Miyazaki, Miyazaki, Japan., Yamada A; Division of Pediatrics, Faculty of Medicine, University of Miyazaki, Miyazaki, Japan., Kinoshita M; Division of Pediatrics, Faculty of Medicine, University of Miyazaki, Miyazaki, Japan., Kamimura S; Division of Pediatrics, Faculty of Medicine, University of Miyazaki, Miyazaki, Japan., Konomoto T; Division of Pediatrics, Faculty of Medicine, University of Miyazaki, Miyazaki, Japan., Nunoi H; Division of Pediatrics, Faculty of Medicine, University of Miyazaki, Miyazaki, Japan. |
| Source: | Cancer medicine [Cancer Med] 2019 Dec; Vol. 8 (18), pp. 7809-7821. Date of Electronic Publication: 2019 Nov 06. |
| Publication Type: | Journal Article; Research Support, Non-U.S. Gov't |
| Journal Info: | Publisher: John Wiley & Sons Ltd Country of Publication: United States NLM ID: 101595310 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2045-7634 (Electronic) Linking ISSN: 20457634 NLM ISO Abbreviation: Cancer Med Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| ISSN: | 2045-7634 |
|---|---|
| DOI: | 10.1002/cam4.2647 |
